日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Computationally Designed Prefusion Stabilized Human Metapneumovirus Fusion Protein Vaccine Antigen Elicited a Potent Neutralization Response.

经计算机设计的预融合稳定化人偏肺病毒融合蛋白疫苗抗原引发了强效的中和反应

Kishko Michael, Stuebler Antonia, Sasmal Sukanya, Chan Yvonne, Huang Dean, Reyes Christopher, Lin Jasmine, Price Owen, Kume Ana, Zong Katie, Bricault Christine, Alamares-Sapuay Judith, Zhang Linong

Epitope Profiling of SARS-CoV-2 Spike Antigen Provides a Novel Strategy for Developing ELISAs Specific for Different Spike Protein Variants in Bivalent Vaccine Formulations.

SARS-CoV-2 刺突抗原的表位分析为开发针对二价疫苗制剂中不同刺突蛋白变体的特异性 ELISA 提供了一种新策略

Ettorre Luciano, Williams Trevor, Houy Camille, Zhu Shaolong, Kishko Michael, Azizi Ali, James Andrew D, Gajewska Beata, Szeto Jason

Mutations in the F protein of the live-attenuated respiratory syncytial virus vaccine candidate ΔNS2/Δ1313/I1314L increase the stability of infectivity and content of prefusion F protein

减毒活呼吸道合胞病毒候选疫苗ΔNS2/Δ1313/I1314L的F蛋白突变提高了感染性的稳定性以及融合前F蛋白的含量。

Judith Alamares-Sapuay,Michael Kishko,Charles Lai,Mark Parrington,Simon Delagrave,Richard Herbert,Ashley Castens,Joanna Swerczek,Cindy Luongo,Lijuan Yang,Peter L Collins,Ursula J Buchholz,Linong Zhang

Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates

COVID-19 β 变体蛋白加强疫苗在非人类灵长类动物中引发对 SARS-CoV-2 变体的持久交叉中和作用

Vincent Pavot #, Catherine Berry #, Michael Kishko, Natalie G Anosova, Lu Li, Tim Tibbitts, Dean Huang, Alice Raillard, Sylviane Gautheron, Cindy Gutzeit, Marguerite Koutsoukos, Roman M Chicz, Valerie Lecouturier

Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters

含β蛋白的双价SARS-CoV-2疫苗在恒河猴中引起持久的广泛中和作用,并在仓鼠中引起保护作用

Catherine Berry #, Vincent Pavot #, Natalie G Anosova, Michael Kishko, Lu Li, Tim Tibbitts, Alice Raillard, Sylviane Gautheron, Sheila Cummings, Dinesh S Bangari, Swagata Kar, Caroline Atyeo, Yixiang Deng, Galit Alter, Cindy Gutzeit, Marguerite Koutsoukos, Roman M Chicz, Valerie Lecouturier

Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates

基于蛋白质的 SARS-CoV-2 刺突疫苗增强剂可增强非人类灵长类动物对 SARS-CoV-2 令人担忧的变体的交叉中和作用

Vincent Pavot #, Catherine Berry #, Michael Kishko, Natalie G Anosova, Dean Huang, Tim Tibbitts, Alice Raillard, Sylviane Gautheron, Cindy Gutzeit, Marguerite Koutsoukos, Roman M Chicz, Valerie Lecouturier

Immunogenicity and protective efficacy of RSV G central conserved domain vaccine with a prefusion nanoparticle

预融合纳米颗粒RSV G中心保守结构域疫苗的免疫原性和保护效果

Jennifer N Rainho-Tomko #, Vincent Pavot #, Michael Kishko #, Kurt Swanson #, Darin Edwards, Heesik Yoon, Lilibeth Lanza, Judith Alamares-Sapuay, Robert Osei-Bonsu, Sophia T Mundle, Dave A Murison, Scott Gallichan, Simon Delagrave, Chih-Jen Wei, Linong Zhang, Gary J Nabel

Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model

非人灵长类动物免疫原性模型中第三次加强免疫后的泛SARS中和反应

Kirill V Kalnin, Timothy Plitnik, Michael Kishko, Dean Huang, Alice Raillard, Julie Piolat, Natalie G Anosova, Timothy Tibbitts, Joshua DiNapoli, Shrirang Karve, Rebecca Goldman, Hardip Gopani, Anusha Dias, Khang Tran, Minnie Zacharia, Xiaobo Gu, Lianne Boeglin, Jonathan Abysalh, Jorel Vargas, Angel

Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models

mRNA COVID-19 疫苗 MRT5500 在临床前动物模型中的免疫原性和有效性

Kirill V Kalnin, Timothy Plitnik, Michael Kishko, Jinrong Zhang, Donghui Zhang, Adrien Beauvais, Natalie G Anosova, Tim Tibbitts, Josh DiNapoli, Gregory Ulinski, Peter Piepenhagen, Sheila M Cummings, Dinesh S Bangari, Susan Ryan, Po-Wei D Huang, James Huleatt, Deanne Vincent, Katherine Fries, Shrira

Roughness of Transmembrane Helices Reduces Lipid Membrane Dynamics

跨膜螺旋的粗糙度会降低脂质膜的动力学特性

Olšinová, Marie; Jurkiewicz, Piotr; Kishko, Iryna; Sýkora, Jan; Sabó, Ján; Hof, Martin; Cwiklik, Lukasz; Cebecauer, Marek